Faron Pharmaceuticals

0,48 EUR

-0,62%

5.705 følger denne virksomhed
Kunde

FARON

First North Finland

Biotechnology & Pharmaceuticals

Health Care

Værdiansættelse

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Faron Pharmaceuticals

Udbytteprocent

Medianen 2021-2025

P/B

Medianen 2021-2025

 
20192020202120222023202420252026e2027e2028e2029e
Aktiekurs (EUR)3,302,913,243,713,772,242,450,480,480,480,48
Aktier43,346,953,259,868,8104,6118,6222,8246,1265,5265,5
Markedsværdi142,9136,5172,5221,6259,3234,4290,5107,6118,9128,2128,2
Enterprise value138,2135,1169,0227,5265,3236,7302,6102,4130,4156,2168,4
EV/S34.556,033.775,442.241,456.880,566.337,259.166,275.657,025.596,032.609,639.043,1159,9
EV/EBITDAneg.neg.neg.neg.neg.neg.neg.neg.neg.neg.neg.
EV/EBIT (adj.)neg.neg.neg.neg.neg.neg.neg.neg.neg.neg.neg.
EV/EBITneg.neg.neg.neg.neg.neg.neg.neg.neg.neg.neg.
P/E (adj.)neg.neg.neg.neg.neg.neg.neg.neg.neg.neg.neg.
P/Eneg.neg.neg.neg.neg.neg.neg.neg.neg.neg.neg.
P/B88,7neg.58,8neg.neg.neg.neg.83,8neg.neg.neg.
P/S35.714,334.117,343.117,955.389,864.831,558.589,472.618,026.905,529.721,432.054,3121,8
Udbytteprocent0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %
Equity ratio15,8 %-22,1 %22,3 %-101,8 %-148,4 %-78,0 %-107,8 %3,3 %-133,4 %-523,3 %-615,2 %
Gearing ratio-287,8 %73,9 %-119,5 %-52,0 %-39,7 %-23,6 %-65,7 %-407,9 %-73,5 %-86,6 %-85,4 %